#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile spasms Castleman's disease Glomerulonephritis membranoproliferative Hereditary optic atrophy Endometrial adenocarcinoma Cold type haemolytic anaemia Paroxysmal nocturnal haemoglobinuria Fibrosarcoma metastatic Cerebellar ataxia Blood iron increased Ependymoma Vulval cancer Gaucher's disease type III Myasthenia gravis Deafness neurosensory More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Metachromatic leukodystrophy Nephroblastoma – Basic Information Lymphangiosarcoma – Diagnostics Factor IX deficiency – Treatment Piriformis syndrome – Life with Disease Vascular malformation Stevens-Johnson syndrome – Treatment Leiomyosarcoma recurrent – Treatment Erdheim-Chester disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brimonidine TEV-53408 Imidapril Hydrochloride VERT-002 POTASSIUM HYDROXIDE Temocillin Lutetium (177Lu) Oxodotreotide Tenecteplase Clemastine Mva-209-Fsp-B2 Procarbazine Raxtozinameran Rizolipase Salbutamol Sulfate Epirubicin Cortisone Acetate Belumosudil Mesilate Risedronate Sodium PF-07868489 Oxybuprocaine More therapies…

    Learn about Your Condition

    Hypophosphatasia Hyperadrenocorticism Congenital pseudarthrosis Drug dependence Sarcoma Post-traumatic stress disorder Hypertriglyceridaemia Congenital ureteric anomaly Peritonitis Hypopituitarism Subdural haematoma Spondylolisthesis Amnestic disorder Dyslipidaemia Rhabdoid tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy…

Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy

Ul. Marii Curie Sklodowskiej 9, Bydgoszcz, 85-094, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Poland

  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urticaria cholinergic
    • Urticaria chronic
    • Cold urticaria
    Investigated Drugs:
    • Remibrutinib
    France Germany Hungary Italy The Netherlands Poland +4

  • Study on the Safety and Effectiveness of Brexucabtagene Autoleucel for Children and Teens with Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    • Non-Hodgkin’s lymphoma
    • Non-Hodgkin’s lymphoma refractory
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    Czechia France Germany Italy Poland Spain

  • Study on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ivabradine
    Poland

  • Study of dapagliflozin effects in patients hospitalized with acute heart failure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    Czechia Hungary Poland

  • Study on the Effect of Food on Selumetinib in Adolescents with Neurofibromatosis Type 1 Plexiform Neurofibromas

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Selumetinib
    Poland

  • Study on the Effectiveness and Safety of Obinutuzumab and Tacrolimus for Patients with Primary Membranous Nephropathy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    Investigated Drugs:
    • Tacrolimus
    • Obinutuzumab
    France Italy Poland Spain

  • Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Selumetinib
    France Germany Italy Poland Spain

  • Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Other Hormone Antagonists And Related Agents
    • Tumour Detection
    • Apalutamide
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on the Effects of Trimetazidine on Heart Failure with Preserved Ejection Fraction in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Trimetazidine Dihydrochloride
    Poland
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!